|
|
||||||||
1From the Department of Zoology and Genetics and the 2Neuroscience Program, Iowa State University, Ames, Iowa; and the 3Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
| Abstract |
|---|
|
|
|---|
METHODS. Enhanced green fluorescent protein (GFP)expressing murine brain progenitor cells were transplanted into developing and mature Brazilian opossums (Monodelphis domestica). Animals were allowed to survive for up to 4 weeks after transplantation, at which time the eyes were prepared for immunohistochemical analysis.
RESULTS. Transplanted mBPCs survived and differentiated in vivo, and extensive morphologic integration was observed within the host retinas. GFP-expressing cells often displayed morphologies characteristic of retinal neurons. GFP somata were located in nuclear layers, and their processes ramified throughout the inner (IPL) and outer (OPL) plexiform layers. Furthermore, in some cases, GFP-expressing neurites were confined to specific sublamina within the IPL. The greatest morphologic integration and differentiation were observed after transplantation into the youngest-aged host eyes. Some transplanted mBPCs incorporated within the inner retina expressed the neuronal markers microtubule associated protein (MAP)-2 or calretinin. Transplanted cells coexpressed GFP and recoverin only in the ONL.
CONCLUSIONS. mBPCs survived and morphologically integrated after xenotransplantation without immunosuppression. mBPCs were capable of incorporating into specific layers of the retina and expressing neuronal and retinal markers. The age of the host appeared to play a key role in determining cell fate in vivo.
The work of Gage et al.5 revealed that isolated progenitor cells from the adult rat hippocampus retain the capacity to generate mature neurons when transplanted into the adult brain. Furthermore, these cells are capable of functionally integrating into the host hippocampal circuitry.6 When transplanted into neonatal or adult eyes, adult rat hippocampal progenitor cells survive, migrate, integrate, and in some cases differentiate into what appear to be mature neurons, but fail to differentiate into cells of retina-specific lineages.7 8 9 Although the normal immature retina is receptive to the integration of transplanted progenitor cells, the studies just cited show that a damaged retinal environment, induced mechanically8 or by transient ischemia,10 is needed to induce incorporation and differentiation of transplanted progenitor cells in mature hosts. Similarly, differentiation and morphologic integration of adult rat hippocampal progenitor cells has been observed in mature dystrophic rat retinas,9 but not in the congenic control. These results show that damaged or diseased environments are capable of supporting the differentiation of transplanted neural stem cells. Taken together, the findings in these studies suggest that incorporation of transplanted neural stem cells into the mature host neural retina cannot occur unless the tissue is damaged. Furthermore, it appears that the age of the recipient may affect the degree of integration after transplantation. This hypothesis, however, has remained relatively untested due to the limitations of performing transplants at embryonic or fetal stages.
In this report, we present a novel system for investigating such developmental questions. The Brazilian opossum, Monodelphis domestica, is a pouchless marsupial born in an extremely immature, fetal-like state. Brazilian opossum pups undergo an extensive period of postnatal development.11 Access to an embryonic-like environment provides an excellent model system with which to investigate the fate of progenitor cells in vivo. Using enhanced green fluorescent protein (GFP)expressing neural progenitor cells isolated from neonatal mice,2 we investigated the cells survival, integration, and differentiation after transplantation into the developing and mature opossum eye. We present the first systematic study showing the fate of murine brain progenitor cells (mBPCs) after transplantation into the developing environment of the eye.
| Materials and Methods |
|---|
|
|
|---|
80%) and kept on a 14/10-hour lightdark cycle. Animals were provided with food and water ad libitum (Reproduction Fox Chow, Milk Specialties Products, Madison, WI) and fresh fruit. Gestation was approximately 13.5 days and litters of 3 to 13 pups were obtained. The day of birth was designated as postnatal day 1 (1 PN). Eye opening occurred at approximately 35 PN, and pups were weaned from their mothers at 60 PN. Pups of ages 5 to 35 PN (n = 28) and mature animals of 79 PN and 2.5 years (n = 8) of age were used in this study. All animal procedures for this study adhered to the provisions of the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and had the approval of the Iowa State University Committee on Animal Care, and were performed in accordance with committee guidelines.
Murine Brain Progenitor Cell Culture
The murine brain progenitor cells (mBPCs) used in this study were isolated from brains of newborn enhanced green fluorescent protein (GFP)expressing transgenic mice (TgN(ß-act-eGFP)04Obs)12 as reported by Shatos et al.2 Murine brain progenitor cells were maintained as neurospheres in plastic tissue culture flasks (T-25 Falcon; Fisher Scientific, Pittsburgh, PA) in complete culture medium containing DMEM/Hams F12 1:1 (Omega Scientific, Tarzana, CA) supplemented with N2 (Life Technologies, Rockville, MD), nystatin suspension (Life Technologies), penicillin-streptomycin (Sigma, St. Louis, MO), epidermal growth factor 20 ng/mL (recombinant human EGF; Life Technologies), and basic fibroblast growth factor 20 ng/mL (human recombinant bFGF; Promega Corp., Madison, WI). For in vitro analysis, mBPCs were collected by centrifugation at 800g for 3 minutes and the pellets resuspended in conditioned culture medium. The cells were then plated on 12-mm poly-L-ornithine-laminin or poly-L-lysinecoated glass coverslips. To prepare the substrates, the coverslips were washed with detergent (2% RBS; Pierce Chemical Co, Rockford, IL), coated with 50 µL/mL poly-L-ornithine (Sigma) in sterile water, incubated overnight, washed, and coated with 5 µg/mL mouse-derived laminin (Mouse; BD Biosciences, Bedford, MA) in phosphate-buffered saline (PBS, 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4 per liter ddH2O [pH 7.4]) for 6 to 8 hours. Laminin-coated coverslip substrates were used immediately after preparation. Coverslips were also coated with 1 mg/mL poly-L-lysine prepared in borate buffer (310 mg H3BO3, 475 mg Na2B4O7, 10 H2O in 100 mL ddH2O [pH 8.4]) and incubated for 3 hours. Coated coverslips were rinsed in culture water, air dried, and used as needed. No clear difference in the number of attached cells was observed with either substrate. To begin the differentiation process, the neurospheres were harvested, dissociated, and plated onto substrate-coated glass coverslips in medium without bFGF and EGF (referred to as differentiation medium).
Transplantation of mBPCs into the Developing Eye
Cultured mBPCs were collected as spheres within the culture medium and spun at 800g for 3 minutes, after which the pelleted mBPCs were resuspended in Dulbeccos PBS (Life Technologies). Adult animals were anesthetized in an induction chamber. Anesthesia was induced with 3% halothane combined with 30% NO and 70% O2 and was maintained with 1.5% halothane in NO and O2 for the duration of the experimental procedure. Opossum pups remain attached securely to the mothers nipples until 20 PN. When performing transplantations on 5, 8, and 10 PN pups, the mother was anesthetized in the halothane induction chamber (as described above) with the litter still attached. Older pups were anesthetized individually.
The cell injection apparatus consisted of a 20-µL syringe (Hamilton, Reno, NV) connected through a 0.9% saline-filled polyethylene tube to a beveled glass micropipette. Animals received intraocular injections of mBPCs through the dorsolateral aspect of the eye. Two microliters of cell suspension (
50,000 cells/µL) was slowly injected into the vitreal chamber of adult eyes and 1.0 to1.5 µL into the eyes of younger hosts. An aliquot of cells used for each transplantation session was plated into a sterile culture dish and visualized with fluorescence microscopy to verify the viability and GFP expression of the transplanted cells. Animals were monitored daily, and those receiving transplants were allowed to survive for 1, 2, and 4 weeks. After appropriate survival periods the opossum pups and adults were deeply anesthetized with halothane and perfused transcardially with 4% paraformaldehyde in 0.1 M PO4 buffer. The heads were removed and postfixed for 48 hours in 4% paraformaldehyde. Eyes were removed, immersion fixed for an additional 2 to 6 hours, and cryoprotected in 30% sucrose in 0.1 M PO4 buffer. Tissue was embedded in optimal cutting temperature (OCT) compound (Tissue-Tek; VWR International, West Chester, PA) frozen and sectioned coronally at 20 µm using a cryostat (American Optical, Buffalo, NY). Sections were thaw mounted onto microscope slides (Superfrost; Fisher Scientific) and stored at -20°C until processed.
Analysis of mBPCs In Vitro: Immunocytochemistry
Cells cultured on coverslips were processed for immunocytochemistry according to standard protocols. Briefly, cells were first rinsed on 0.1 M PO4 buffer, fixed in 4% paraformaldehyde in 0.1 M PO4, rinsed, and processed as described for tissue sections. Specific primary antibodies (see Antibodies section) were used to identify differentiated neurons and glia. Cultured cells were incubated in primary antibodies for 18 hours, rinsed, and subsequently incubated in the dark for 2 hours in fluorescent conjugated secondary antibody. They were then rinsed and mounted on microscope slides with antifade mounting medium (Vectashield; Vector Laboratories, Burlingame, CA). Antibody experiments were repeated three times with cells plated from separate culturing sessions.
Preparations were examined on a photomicroscope (Microphot FXA; Nikon Corp., Melville, NY). A 20x objective was used to examine 6 to 10 microscope fields, each field representing 0.1 mm2 (360 x 280 µm). In each microscope field the following counts were made: total number of cells (using light microscopy), number of cells expressing GFP (using an FITC filter cube), and number of cells labeled with the primary antibody of interest (using a rhodamine isothiocyanate [RITC] filter cube). These data were used to calculate the percentage of GFP-expressing cells labeled with one of the antibody markers on each coverslip. The data collected after 1 and 3 days in culture, in both complete and differentiation media for each antibody was compared and analyzed using a two-sample, student t-test. All data analyses were performed blind, to eliminate experimental bias.
Analysis of Tissue Sections: Immunohistochemistry
Sections were washed in potassium PBS (KPBS; 0.15 M NaCl, 0.034 M K2HPO4, 0.017 M KH2PO4 [pH 7.4]) and incubated in blocking solution (1.5% blocking serum, 1% bovine serum albumin [BSA; Sigma], and 0.4% Triton X-100, Fisher Scientific) for 2 hours. Sections were incubated in primary antibody overnight at room temperature in a humid chamber, washed in KPBS with Triton X-100, incubated in appropriate biotinylated secondary antibodies for 2 hours, rinsed, and incubated with streptavidin Cy3 (Jackson ImmunoResearch, West Grove, PA) in the dark for 30 minutes. Slides were then rinsed and coverslipped with antifade mounting medium (Vectashield; Vector Laboratories).
Bromodeoxyuridine Injection and Analysis
Opossum pups were injected with bromodeoxyuridine (BrdU) at 5, 10, and 20 PN. Individual pups were injected without separation from the mother. Each pup (n = 3 at each time point) was given a subcutaneous injection of 1.5 µL of 20 mg/mL BrdU solution (in sterile saline) along the dorsal midline. Pups were allowed to survive for 2 hours, at which time the tissue was prepared for immunohistologic analysis, as previously described.13 Briefly, tissue sections were rinsed with KPBS and pretreated with 0.06% trypsin (bovine type III; Sigma) and 5.4 x 10-3 M CaCl2 in KPBS for 30 minutes at 37°C. After washing for 10 minutes with KPBS, tissue was treated with 0.1 N HCl for 10 minutes, followed by incubation in 2 N HCl at 37°C for 30 minutes. The tissue sections were neutralized in basic 0.5 M KPBS (pH 8.5) and subsequently processed for routine immunohistochemistry with an anti-BrdU antibody.
Antibodies
Anti-microtubule associated protein (MAP)-2 (mouse IgG; Roche Molecular Biochemicals, Indianapolis, IN) was diluted at 1:1000 in blocking solution and used as a marker of ganglion cells and the inner plexiform layer (IPL).14 An antibody against class III ß-tubulin (TUJ1) was used as a neuronal marker and was diluted at 1:200 (mouse IgG; Chemicon International, Temecula, CA)., Anti-glial fibrillary acidic protein (GFAP; GA5, mouse IgG; ICN Immunobiologicals, Costa Mesa, CA) was diluted at 1:1000 and used as a marker of astrocytes and reactive Müller glia of the retina.15 Anti-calretinin was used to identify this calcium-binding protein (rabbit IgG; Chemicon), which has been used as a marker of a subclass of horizontal cells, amacrine cells, and ganglion cells,16 17 and was diluted at 1:3000. Anti-synaptogamin I (P65, mouse IgG obtained from Reinhard Jahn, Howard Hughes Medical Institute [HHMI], Yale University, New Haven, CT) was diluted at 1:2000. Anti-recoverin (rabbit IgG, obtained from Alexander Dizhoor, Wayne State University, Detroit, MI) was diluted at 1:2000 and used as a marker of photoreceptors.18 The O4 antibody (1:400, mouse IgM, Chemicon) was used as a marker for oligodendrocytes. BrdU was detected using anti-BrdU (rat 1:2000; Dako Corp., Carpinteria, CA). All primary and secondary antibodies were diluted in KPBS with 1% BSA, 0.4% Triton X-100, and 1% normal blocking serum, corresponding to the species in which the secondary antibody was produced. All biotinylated secondary antibodies (horse anti-mouse and goat anti-rabbit; Jackson ImmunoResearch) were diluted to 1:500. Streptavidin Cy3 was diluted in KPBS to 1:10,000. Negative controls were used in parallel during all immunohistologic processing by the omission of the primary or secondary antibody. No antibody labeling was observed in the control experiments.
Analysis of Tissue Sections
Tissue sections containing transplanted GFP-expressing mBPCs and labeled with the antibodies were examined with a photomicroscope (Microphot FXA; Nikon Corp.). Retinas that received transplanted mBPCs were compared with control, noninjected, age-matched retinas to determine whether normal morphologic development had occurred during the survival period after transplantation. Murine brain progenitor cells were analyzed for location, morphology, and colocalization of antibody markers. Images were captured with a charge-coupled device camera (Megaplus; Model 1.4; Kodak Corp., San Diego, CA) connected to a framemaker (MegaGrabber; Perceptics, Knoxville, TN, in a Macintosh 8100/80AV computer; Apple Computer, Cupertino, CA) using NIH Image 1.58VDM software (available by ftp from zippy.nimh.nih.gov; Wayne Rasband, National Institutes of Health, Bethesda, MD). Some sections were visualized and images captured using a confocal scanning laser microscope (TCS-NT; Leica Microsystems Inc., Exton, PA). Figures were prepared on computer (iMac, Power PC G3; Apple Computer, using Photoshop, ver. 4.0, Adobe, San Jose, CA, and Freehand, ver. 9.0, for the Macintosh; Macromedia, San Francisco, CA). Outputs were generated on a continuous-tone color printer (Phaser; Tectronix, Beaverton, OR).
Reconstruction of GFP-Expressing mBPCs Integrated into the Retina
Reconstructions were drawn from a series of six to eight confocal images of the same cell. Confocal image series were obtained from eight retinas. Reconstructed images were digitized with a flatbed scanner (Astra 2400S; UMAX Corp., Fremont, CA, final image constructed in Freehand ver. 9.0; Macromedia).
| Results |
|---|
|
|
|---|
|
Specific antibodies were used to assess the phenotypes of the mBPCs after culturing 1 and 3 days, in the presence or absence of the growth factors. Figure 2 illustrates the expression of MAP2, TUJ1, and GFAP in populations of GFP-expressing mBPCs. Many mBPCs expressed MAP2 and TUJ1, proteins characteristic of neurons. These cells often displayed neuronal morphologies but could also be round cells with small somata. MAP2-immunoreactive (IR) cells often displayed extensive processes as well as more simple bipolar morphologies. The TUJ1 antibody revealed extensive detail of the neurites (Figs. 1 2) . In contrast, cells were rarely labeled with the anti-GFAP antibody. GFAP IR was detected in cells displaying a mature glial morphology with star-shaped, short, broad processes (Fig. 2) .
|
|
|
|
Two Weeks after Transplantation.
GFP-expressing mBPCs were again found throughout the posterior segment of the eye 2 weeks after transplantation. In contrast to tissue analyzed after 1 week, more cells were adjacent to the ILM. Although mBPC somata were seldom observed within the nuclear layers of the retina, GFP-expressing processes were present within the ganglion cell layer (GCL) and IPL. At 2 weeks after transplantation most mBPCs were observed bordering the inner retina or abutting the lens within the eyes of the youngest hosts (5, 8, and 10 PN). Transplanted cells within older hosts (30, 34, and 79 PN) were generally dispersed within the vitreous of the posterior segment; however, these cells displayed more differentiated morphologies. Cells in these older hosts rarely integrated or associated with the ILM. We observed GFP-expressing mBPCs throughout the eye at 2 weeks after transplantation, suggesting the transplanted cells may be capable of longer-term survival. After 2 weeks survival, it became apparent that the hosts age influenced the fate of cells in vivo. Although still very limited, the younger the host environment, the more incorporation we observed within the host inner retina.
Four Weeks after Transplantation.
At this time point, GFP-expressing mBPCs were incorporated within all layers of the retina after transplantation into 5, 8, and 10 PN hosts (Figs. 4A 4B 5) . Many GFP-expressing cells integrated into the neural retina of 5 and 10 PN hosts (Figs. 5A 5B 5C 5D 5E 5F 5G) . Transplanted mBPCs were observed within the GCL, inner nuclear layer (INL), and outer nuclear layer (ONL). Processes were observed extending throughout the ILM, GCL, IPL and ONL (Figs. 4A 4B 5A 5D 5F) . The lens and the ciliary margin were also attractive environments for mBPC differentiation. Transplanted mBPCs were observed adjacent to and extending into the outer layers of the lens. GFP-expressing cells were throughout the posterior segment of the eye. In striking contrast, mBPCs survived and differentiated morphologically but in general remained within the vitreous or in close contact with the ILM after transplantation into the older and adult hosts (30, 34, and 79 PN; Figs. 4C 4D ). Isolated cells appeared to extend into the inner retina at 34 and 79 PN; however, no somata invaded the host retina at the older ages. At 4 weeks after transplantation, many mBPCs integrated within all nuclear layers of the retina of 5 and 10 PN hosts, but few cells were observed integrated into the more mature host retinas.
|
|
|
|
Evaluation of the Phenotypes Adopted by mBPCs In Vivo
A panel of specific antibodies was used to evaluate whether the transplanted cells adopted mature neural phenotypes in vivo. Within the mammalian retina, MAP2 IR localizes within neurons of the inner retina.21 22 Some GFP-expressing cells expressed MAP2 when located in the inner retina (Fig. 8A) . Integrated cells expressed MAP2 within the GCL and INL. Figure 8A , shows several MAP2-IR cells located within both these nuclear layers. In addition, some GFP-expressing cells located within the vitreous were also MAP2 IR (data not shown). Cells incorporated within the outer layers of the retina were not MAP2 IR.
A subpopulation of GFP-expressing cells were observed to coexpress calretinin (Fig. 8B) . In the mature retina, antibodies against calretinin labels some amacrine and horizontal cells, as well as the IPL.23 24 The merged image in Figure 8B illustrates examples of GFP-expressing cells that coexpressed calretinin (arrows). In some cases the calretinin-IR mBPCs were relatively evenly distributed similar to host cells in the surrounding retina. We observed no calretinin expression within the outer retina.
mBPCs integrated within the ONL did not adopt morphologies characteristic of mature photoreceptors. However, a relatively small subpopulation of GFP-expressing cells coexpressed recoverin, a marker for photoreceptors and cone bipolar cells (Fig. 8C) . The merged image in Figure 8C illustrates a cluster of GFP-expressing somata that coexpressed recoverin. The GFP-expressing cells were located along the inner border of the ONL, adjacent to the OPL.
An antibody against the presynaptic terminal protein P65 was used to determine whether GFP-expressing processes express a synapse-associated protein. In this analysis, very little P65 IR was observed within GFP-expressing processes. However, GFP-expressing processes within the IPL were intertwined among host processes (Fig. 8D) .
We used an antibody against GFAP to determine whether the transplanted cells expressed this glial marker. In this analysis, GFAP IR was observed only among host astrocytes. mBPCs adjacent to and along the inner retina were not GFAP IR. We observed GFAP-IR (at all ages examined) only among mBPCs situated in the vitreous, generally among clusters of GFP-expressing cells (data not shown).
| Discussion |
|---|
|
|
|---|
In Vitro Differentiation of mBPCs
Capable of self-renewing in culture, mBPCs were maintained as neurospheres in growth factorsupplemented culture medium. After plating onto adhesive substrates, mBPCs cultured in the absence of bFGF and epithelial growth factor (EGF) adopted mature cellular phenotypes. mBPCs often adopted elaborate morphologies in vitro and often appeared to interconnect through complex neuritic processes. Using markers against mature neuronal and glial proteins, we observed a significant increase in the number of mBPCs immunoreactive for both MAP2 and TUJ1. Because the culture environment was not manipulated, except for the withdrawal of the mitogenic factors, the potential to express neuronal proteins must be intrinsic to the cell after exiting the cell cycle. Few mBPCs were labeled with the GFAP antibody in either culture condition suggesting more complex regulation of the astrocytic phenotype from these neural progenitor cells. Furthermore, no mBPCs were labeled with the O4 antibody directed against oligodendrocytes,25 26 (data not shown), although the antibody clearly labeled oligodendrocytes in sections of brain tissue.
Survival and Integration of Transplanted mBPCs
After transplantation, the GFP-expressing cells dispersed and migrated throughout the posterior segment of the eye and were easily identified with fluorescence microscopy. As a standard procedure, an aliquot of cells used for transplants was always cultured for 24 hours to verify the condition of the mBPCs at the time of transplantation. These mBPCs always strongly expressed GFP, and thus we are confident that at the time of transplantation the cells were in a healthy condition.
Our results clearly demonstrate that mBPCs were capable of survival after xenotransplantation, even in the absence of immunosuppression. This may be due to the relative purity of cultured mBPCs, which lack antigen-presenting cells and passenger leukocytes that would be present in conventional grafts of neural tissue. A large number of GFP-expressing cells survived after transplantation in all ages of recipient. After 1 week, transplanted cells were observed within the vitreous or adjacent to the lens. After 2 weeks, cells began to integrate within the retina but were not incorporated within the nuclear layers. At 4 weeks after transplantation, mBPCs incorporated within all layers of the younger host retinas (510 PN). The physical barrier of the ILM could prevent invasion of cells into the older retinas.
The incidence of incorporation of GFP-expressing cells decreased with increasing age of the host eye. At 5 and 10 PN, GFP-expressing cells were within all layers of the retina. In general, cells transplanted into older hosts remained in the posterior segment of the eye or aligned themselves along the ILM and were seldom observed integrated into the host tissue. Survival and differentiation cues, such as growth or neurotrophic factors and cellextracellular adhesion molecules are especially abundant early in retinal development.27 28 29 30 It is likely that factors such as these facilitate the survival, differentiation, and migration of the transplanted cells at younger ages. Furthermore, it is possible that immature retinal tissue acts as a weaker physical barrier to the emigration of the mBPCs. The vitreal surface of the developing retina of the youngest hosts (510 PN) is composed principally of the processes of the neuroepithelial progenitor cells, the nascent axons of the retinal ganglion cells (RGCs) and the retinal basal lamina. With continued development, the vitreal surface becomes thicker and more complex as additional RGC axons accumulate on the optic fiber layer. In addition, the ILM is formed by end feet of the Müller glial (retinal gliogenesis begins at approximately 15 PN) and the astrocytes begin migrating into the retina through the optic nerve and line the vitreal surface beginning at approximately 20 to 25 PN. Thus, the increase in physical complexity of the vitreal surface may inhibit or slow the migration of transplanted cells from the posterior chamber into the more mature retinas. It is interesting to note that we observed extensive morphologic integration of the mBPCs 4 weeks after transplantation into the youngest hosts (510 PN). The extensive morphologic integration occurred between 2 and 4 weeks after the transplantation of the mBPCs. In the case of the 10 PN hosts this would correspond to a developmental window between 24 and 38 PN. Transplants in comparable-aged hosts (2438 PN) produced no incorporation. Additional studies are necessary to identify and determine what factors regulate the migration and integration of transplanted neural progenitor cells into the CNS.
Morphologically integrated mBPCs respected the architectural organization of the retina. Transplanted cells were principally localized to the nuclear layers, and their processes organized into appropriate layers based on retinal laminar position. Transplanted mBPCs located within the GCL and inner regions of the INL extended processes into the IPL. In many cases, the processes were restricted to specific sublamina within the IPL, either the ON or OFF sublamina. These results suggest that the migrating mBPCs were capable of detecting molecular cues present within the host retina. It is possible that the cues are intimately involved in regulating the incorporation of the transplanted cells. Of course, we cannot rule out the possibility that the grafted cells are simply restricted mechanically by the host microenvironment and adopt their morphologic attributes due to this mechanism.
Differentiation of mBPCs In Vivo
mBPCs can differentiate in vivo, producing characteristic retinal morphologies. Transplanted mBPCs adopted a variety of morphologies both within the vitreal chamber (all ages) and within the retina of young hosts. Transplanted cells with morphologies reminiscent of amacrine, bipolar, and horizontal cells were in the INL, and cells with morphologies similar to RGCs and displaced amacrine cells were in the GCL. No GFP-expressing cells adopted morphologies characteristic of mature photoreceptors. Our results also suggest mBPCs are capable in vivo of extending long processes after transplantation into 5-PN hosts, as GFP-expressing processes were observed extending within the optic nerve.
Many transplanted cells expressed mature neuronal phenotypes. MAP2 was coexpressed by many GFP-expressing cells positioned within the inner retina and vitreous. Because we observed no MAP2 expression in the mBPCs that were incorporated into the outer layers of the retina, this suggests an endogenous inhibitory signal present in the outer retina that may be involved in the regulation of MAP2. In the host retina, calretinin-IR amacrine cells are located in the inner INL and are equally spaced around the curvature of the retina. GFP-expressing calretinin-IR mBPCs were in locations appropriate for native amacrine cells. GFP-expressing cells located in the ONL were recoverin IR. These cells did not have typical photoreceptor morphologies but were nestled among inner segments of surrounding receptors. No previous study has reported retina-specific differentiation of brain-derived cells. The regionalization of expression of specific neural phenotypic markers by transplanted cells strongly suggests that the mBPCs are capable of responding to local environmental cues within the retina.
Our results are consistent with previous work in rats with transplanted hippocampal progenitor cells.6 7 8 These studies demonstrated that although the mature diseased microenvironment is supportive of progenitor cell integration, only the immature normal retina possesses this property. In the current study we showed that by systematically evaluating recipient age and transplant outcome, we could determine the contribution of the hosts developmental stage to the differentiation capacity of grafted progenitor cells. Future studies are needed to elucidate the molecular mechanism for this effect.
| Conclusion |
|---|
|
|
|---|
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication March 18, 2002; revised July 23, 2002; accepted August 19, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Donald S. Sakaguchi, Department of Zoology and Genetics, 339 Science II, Iowa State University, Ames, IA, 50011; dssakagu{at}iastate.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. B. Samollow The opossum genome: Insights and opportunities from an alternative mammal Genome Res., August 1, 2008; 18(8): 1199 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lawrence, S. Singhal, B. Bhatia, D. J. Keegan, T. A. Reh, P. J. Luthert, P. T. Khaw, and G. A. Limb MIO-M1 Cells and Similar Muller Glial Cell Lines Derived from Adult Human Retina Exhibit Neural Stem Cell Characteristics Stem Cells, August 1, 2007; 25(8): 2033 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Canola, B. Angenieux, M. Tekaya, A. Quiambao, M. I. Naash, F. L. Munier, D. F. Schorderet, and Y. Arsenijevic Retinal Stem Cells Transplanted into Models of Late Stages of Retinitis Pigmentosa Preferentially Adopt a Glial or a Retinal Ganglion Cell Fate Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 446 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, H. Klassen, M. Pries, W. Wang, and M. H. Nissen Aqueous Humor Enhances the Proliferation of Rat Retinal Precursor Cells in Culture, and This Effect Is Partially Reproduced by Ascorbic Acid Stem Cells, December 1, 2006; 24(12): 2766 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liang, R.-T. Yan, W. Ma, H. Zhang, and S.-Z. Wang Exploring RPE as a Source of Photoreceptors: Differentiation and Integration of Transdifferentiating Cells Grafted into Embryonic Chick Eyes Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5066 - 5074. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Meyer, M. L. Katz, J. A. Maruniak, and M. D. Kirk Embryonic Stem Cell-Derived Neural Progenitors Incorporate into Degenerating Retina and Enhance Survival of Host Photoreceptors Stem Cells, February 1, 2006; 24(2): 274 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Young, T. Borras, M. Walter, and R. Ritch Tissue Bioengineering: Potential Applications to Glaucoma Arch Ophthalmol, December 1, 2005; 123(12): 1725 - 1731. [Full Text] [PDF] |
||||
![]() |
K. Warfvinge, J. F. Kiilgaard, E. B. Lavik, E. Scherfig, R. Langer, H. J. Klassen, and M. J. Young Retinal Progenitor Cell Xenografts to the Pig Retina: Morphologic Integration and Cytochemical Differentiation Arch Ophthalmol, October 1, 2005; 123(10): 1385 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Levin, R. Ritch, J. E. Richards, and T. Borras Stem Cell Therapy for Ocular Disorders Arch Ophthalmol, April 1, 2004; 122(4): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Wojciechowski, U. Englund, C. Lundberg, and K. Warfvinge Survival and Long Distance Migration of Brain-Derived Precursor Cells Transplanted to Adult Rat Retina Stem Cells, January 1, 2004; 22(1): 27 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
R R Ali and J C Sowden Therapy may yet stem from cells in the retina Br. J. Ophthalmol., September 1, 2003; 87(9): 1058 - 1059. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |